Evidence map›Paper›PMID 37196759›Full record

ArticleInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases2023

Increasing the initiation of antiretroviral therapy through optimal placement of diagnostic technologies for pediatric HIV in Zimbabwe: A modeling analysis.

Melike Yildirim, Karen A Webb, Andrea L Ciaranello, Alyssa K Amick, Angela Mushavi, Anesu Chimwaza, Anneke Claypool, Tendayi Murape, Nicole C McCann, Clare F Flanagan and 1 more

Abstract read
In one paragraph

Article in International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Melike YildirimMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, USA.
Karen A WebbOrganization for Public Health Interventions and Development, Harare, Zimbabwe; London School of Hygiene and Tropical Medicine, London, United Kingdom.
Andrea L CiaranelloMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Division of Infectious Diseases, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
Alyssa K AmickMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Angela MushaviZimbabwe Ministry of Health and Child Care, National PMTCT Program, Harare, Zimbabwe.
Anesu ChimwazaZimbabwe Ministry of Health and Child Care, National PMTCT Program, Harare, Zimbabwe.
Anneke ClaypoolMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA; Institute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, USA.
Tendayi MurapeOrganization for Public Health Interventions and Development, Harare, Zimbabwe.
Nicole C McCannMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.
Clare F FlanaganMedical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA. Electronic address: CFlanagan2@partners.org.
Mohammad S JalaliInstitute for Technology Assessment, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.

Funding

Innovation across the spectrum of pediatric HIV care: Clinical impact and cost-effectiveness of long-acting antiretroviral therapy for breastfeeding people with HIV and their infants in ZimbabweR01HD079214 · NICHD · MASSACHUSETTS GENERAL HOSPITAL · PI CIARANELLO, ANDREA LYNNE · 2014 to 2023
$8.0M
NICHD NIH HHS R01 HD079214
6 · The paper itself

Abstract

objectivesPoint-of-care (POC) devices for infant HIV testing provide timely result-return and increase antiretroviral (ART) initiation. We aimed to optimally locate POC devices to increase 30-day ART initiation in Matabeleland South, Zimbabwe.

methodsWe developed an optimization model to identify the locations for limited POC devices at health facilities, maximizing the number of infants who receive HIV test results and initiate ART within 30 days of testing. We compared location-optimization model results to non-model-based decision heuristics, which are more practical and less data-intensive. Heuristics assign POC devices based on demand, test positivity, laboratory result-return probability, and POC machine functionality.

resultsWith the current placement of 11 existing POC machines, 37% of all tested infants with HIV were projected to receive results and 35% were projected to initiate ART within 30 days of testing. With optimal placement of existing machines, 46% were projected to receive results and 44% to initiate ART within 30 days, retaining three machines in current locations, moving eight to new facilities. Relocation based on the highest POC device functionality would be the best-performing heuristic decision (44% receiving results and 42% initiating ART withing 30 days); although, it still would not perform as well as the optimization-based approach.

conclusionOptimal and ad hoc heuristic relocation of limited POC machines would increase timely result-return and ART initiation, without further, often costly, interventions. Location optimization can enhance decision-making regarding the placement of medical technologies for HIV care.

Indexed as

HIV InfectionsAnti-Retroviral AgentsChildEarly DiagnosisHumansInfantPoint-of-Care SystemsZimbabweAnti-Retroviral AgentsEarly infant HIV diagnosisLocation optimizationPoint-of-careZimbabwe

Identifiers

PMID37196759
PMCPMC10520845

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.